In conversation with Professor David Segal, Field Chief Editor for Frontiers in Genome Editing
Frontiers
NOVEMBER 19, 2021
He has over 20 years of experience engineering gene and epigenetic systems as molecular tools and therapeutics. David Segal (DS) : I went to the University of Utah for graduate school to work with Mario Capecchi, who would later win the Nobel Prize for “gene targeting”. All the major application areas have emerging hurtles too.
Let's personalize your content